NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. The company's patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. This unique platform may be utilized for a variety of medical applications requiring low cost therapeutic ultrasound qualities. The company's patch-based products include the PainShieldÂŽ and the WoundShieldâ˘, which have gained CE Mark certification. The PainShield also carries FDA clearance. NanoVibronixâ catheter-based products include the UroShield⢠and NG-Shield⢠devices that are both CE mark certified. The Company was founded by Jona Zumeris, Ph.D., an accomplished scientist that invented the Companyâs proprietary low-intensity, surface acoustic wave technology, which allowed it to develop the first ever wearable therapeutic ultrasound devices. Source
No articles found.
Nektar Therapeutics is a research-based development stage biopharmaceutical compan...
Nektar Therapeutics is a research-based develop...
Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headq...
Spok, Inc., a wholly owned subsidiary of Spok H...
Dentsply Sirona is the worldâs largest manufacturer of professional dental produ...
Dentsply Sirona is the worldâs largest manufa...
Siemens Healthineers AG is the holding company of the Siemens Healthineers group. ...
Siemens Healthineers AG is the holding company ...
ââOrthofix Medical Inc. is a diversified, global medical device company focuse...
ââOrthofix Medical Inc. is a diversified, g...
BASi provides drug discovery and development services and analytical instruments t...
BASi provides drug discovery and development se...
Ultrasonic Medical Mapping, Inc., (UMM) is headquartered in Bethesda, MD. The comp...
Ultrasonic Medical Mapping, Inc., (UMM) is head...
Join the National Investor Network and get the latest information with your interests in mind.